fasudil has been researched along with Colonic Neoplasms in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poisson, L | 1 |
| Lopez-Charcas, O | 1 |
| Chadet, S | 1 |
| Bon, E | 1 |
| Lemoine, R | 1 |
| Brisson, L | 1 |
| Ouaissi, M | 1 |
| Baron, C | 1 |
| Besson, P | 1 |
| Roger, S | 1 |
| Moussata, D | 1 |
1 other study available for fasudil and Colonic Neoplasms
| Article | Year |
|---|---|
Rock inhibition promotes Na
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Cell Line, Tumor; Cell Movement; Colonic Neop | 2020 |